Minapharm Pharmaceuticals (CAI:MIPH) EV-to-EBIT : (As of Jun. 19, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Minapharm Pharmaceuticals's Enterprise Value is E£4,221 Mil. Minapharm Pharmaceuticals does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate Minapharm Pharmaceuticals's EV-to-EBIT at this moment.

The historical rank and industry rank for Minapharm Pharmaceuticals's EV-to-EBIT or its related term are showing as below:

CAI:MIPH' s EV-to-EBIT Range Over the Past 10 Years
Min: 0 Med: 0 Max: 15.61
Current: 14.68

During the past 2 years, the highest EV-to-EBIT of Minapharm Pharmaceuticals was 15.61. The lowest was 0.00. And the median was 0.00.

CAI:MIPH's EV-to-EBIT is ranked better than
57.25% of 669 companies
in the Drug Manufacturers industry
Industry Median: 17.12 vs CAI:MIPH: 14.68

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Minapharm Pharmaceuticals's Enterprise Value for the quarter that ended in Dec. 2022 was E£2,625 Mil. Minapharm Pharmaceuticals does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate Minapharm Pharmaceuticals's Earnings Yield (Joel Greenblatt) % at this moment.

Minapharm Pharmaceuticals EV-to-EBIT Historical Data

The historical data trend for Minapharm Pharmaceuticals's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals EV-to-EBIT Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

EV-to-EBIT

2.79

16.11

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Dec23
EV-to-EBIT	-	-

Competitive Comparison of Minapharm Pharmaceuticals's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minapharm Pharmaceuticals's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's EV-to-EBIT falls into.

Minapharm Pharmaceuticals EV-to-EBIT Calculation

Minapharm Pharmaceuticals's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	4220.879	/
	=

Minapharm Pharmaceuticals (CAI:MIPH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Minapharm Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2022 )	=	EBIT	/	Enterprise Value (Q: Dec. 2022 )
	=		/	2625.242814
	=	%

Minapharm Pharmaceuticals EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals (CAI:MIPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

http://www.minapharm.com

Minapharm Pharmaceuticals produces prescription drugs in Egypt and the Middle East. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals (CAI:MIPH) Headlines

No Headlines